Clinical Trial Update: Sirolimus in the Treatment for Infantile Hepatic Hemangioendothelioma(IEEH) [Phase 4]

View source ↗

Summary

Phase 4 trial update investigating sirolimus for infantile hepatic hemangioendothelioma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemangioendothelioma of the Liver

Drugs mentioned

• Sirolimus (Sirolimus)

Snippet

Sponsor: Shanghai Children's Medical Center | Conditions: Hemangioendothelioma of Liver | Phase 4 | Status: UNKNOWN